OBJECTIVE: This study evaluated serum levels of the neuropeptides calcitonin gene-related peptide (CGRP) and substance P (SP) in coronary artery disease (CAD) patients with and without a history of diabetes mellitus (DM). METHODS: Patients undergoing coronary angiography for suspected myocardial ischaemia were divided into four groups depending on their clinical status: control group (no CAD or DM; n = 44), DM group (DM without CAD; n = 46), CAD group (stable CAD without DM; n = 44) and DM + CAD group (stable CAD with DM; n = 50). Serum levels of CGRP and SP were determined using radioimmunoassays. RESULTS: CGRP and SP levels in the DM and CAD groups were significantly lower than in the control group. The lowest levels of CGRP and SP were observed in the DM + CAD group. There were no significant differences in CGRP and SP levels between the DM group and the CAD group. CONCLUSION: CGRP and SP may have a role in the pathogenesis of CAD in patients with diabetes.
GrundySMBenjaminIJBurkeGL: Diabetes and cardiovascular disease: A statement for healthcare professionals from the American Heart Association. Circulation1999; 100: 1134–1146.
2.
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA2001; 285: 2486–2497.
3.
BartnikMRydénLFerrariR: The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J2004; 25: 1880–1890.
4.
HuDYPanCYYuJM: The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey. Eur Heart J2006; 27: 2573–2579.
5.
Centers for Disease Control and Prevention: National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States. Atlanta: Department of Health and Human Services, Centers for Disease Control and Prevention, 2005.
6.
KruglikovIGryshchenkoOShutovL: Diabetes-induced abnormalities in ER calcium mobilization in primary and secondary nociceptive neurons. Pflugers Arch2004; 448: 395–401.
7.
SongJXWangLHYaoL: Impaired transient receptor potential vanilloid 1 in streptozotocin-induced diabetic hearts. Int J Cardiol2009; 134: 290–292.
8.
WangLWangDH: TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation2005; 112: 3617–3623.
9.
HowdenCWLogueCGavinK: Haemodynamic effects of intravenous human calcitonin-gene-related peptide in man. Clin Sci (Lond)1988; 74: 413–418.
10.
HuCPXiaoLDengHW: The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts. Planta Med2002; 68: 705–709.
11.
WeiZWangLHanJ: Decreased expression of transient receptor potential vanilloid 1 impairs the postischemic recovery of diabetic mouse hearts. Circ J2009; 73: 1127–1132.
12.
MiddletonJ: Experience with a glucose-oxidase method for estimating glucose in blood and C.S.F. Br Med J1959; 1: 824–826.
13.
ManziniSPerrettiFDe BenedettiL: A comparison of bradykinin- and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of substance P and calcitonin gene-related peptide release. Br J Pharmacol1989; 97: 303–312.
14.
HooverDB: Effects of capsaicin on release of substance P-like immunoreactivity and physiological parameters in isolated perfused guinea-pig heart. Eur J Pharmacol1987; 141: 489–492.
15.
Franco-CerecedaASariaALundbergJM: Differential release of calcitonin gene-related peptide and neuropeptide Y from the isolated heart by capsaicin, ischaemia, nicotine, bradykinin and ouabain. Acta Physiol Scand1989; 135: 173–187.
16.
MilnerPRalevicVHopwoodAM: Ultrastructural localisation of substance P and choline acetyltransferase in endothelial cells of rat coronary artery and release of substance P and acetylcholine during hypoxia. Experientia1989; 45: 121–125.
17.
LundbergJMFranco-CerecedaAHuaX: Co-existence of substance P and calcitonin gene-related peptide-like immunoreactivities in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol1985; 108: 315–319.
18.
HooverDBHosslerFE: Vasoconstrictor and dilator responses to neurokinin A in isolated guinea pig heart. Peptides1993; 14: 29–36.
19.
ZahnerMRLiDPChenSR: Cardiac vanilloid receptor 1-expressing afferent nerves and their role in the cardiogenic sympathetic reflex in rats. J Physiol2003; 551: 515–523.
20.
SaitoAKimuraSGotoK: Calcitonin gene-related peptide as potential neurotransmitter in guinea pig right atrium. Am J Physiol1986; 250: H693–H698.
21.
SugiyamaAKobayashiMTsujimotoG: The first demonstration of CGRP-immunoreactive fibers in canine hearts: coronary vasodilator, inotropic and chronotropic effects of CGRP in canine isolated, blood-perfused heart preparations. Jpn J Pharmacol1989; 50: 421–427.
22.
UrenNGSeydouxCDaviesGJ: Effect of intravenous calcitonin gene related peptide on ischaemia threshold and coronary stenosis severity in humans. Cardiovasc Res1993; 27: 1477–1481.
23.
WangZGuoJWangX: A study for the relationship between serum calcitonin gene-related peptide and coronary arteriopathy. Zhonghua Nei Ke Za Zhi2001; 40: 750–752 [in Chinese, English abstract].
24.
LechleitnerPGenserNMairJ: Calcitonin gene-related peptide in patients with and without early reperfusion after acute myocardial infarction. Am Heart J1992; 124: 1433–1439.
25.
PittengerGLRayMBurcusNI: Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care2004; 27: 1974–1979.
26.
SchmidtREPluradSB: Ultrastructural and biochemical characterization of autonomic neuropathy in rats with chronic streptozotocin diabetes. J Neuropathol Exp Neurol1986; 45: 525–544.
27.
FaermanIFaccioEMileiJ: Autonomic neuropathy and painless myocardial infarction in diabetic patients. Histologic evidence of their relationship. Diabetes1977; 26: 1147–1158.
28.
ClausDFeistelHBrunhölzlC: Investigation of parasympathetic and sympathetic cardiac innervation in diabetic neuropathy: heart rate variation versus meta-iodo-benzylguanidine measured by single photon emission computed tomography. Clin Auton Res1994; 4: 117–123.
29.
DonnellyREmslie-SmithAMGardnerID: ABC of arterial and venous disease: vascular complications of diabetes. BMJ2000; 320: 1062–1066.
30.
HuxleyRBarziFWoodwardM: Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ2006; 332: 73–78.
